Catalyst Pharmaceuticals
Trade Catalyst Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CPRX
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E.
CPRX Key Statistics
Stock Snapshot
Catalyst Pharmaceuticals(CPRX) stock is priced at $22.55, giving the company a market capitalization of 2.77B. It carries a P/E multiple of 13.55.
On 2026-01-14, Catalyst Pharmaceuticals(CPRX) stock traded between a low of $22.32 and a high of $22.73. Shares are currently priced at $22.55, which is +1.0% above the low and -0.8% below the high.
Catalyst Pharmaceuticals(CPRX) shares are trading with a volume of 206.03K, against a daily average of 1.25M.
In the last year, Catalyst Pharmaceuticals(CPRX) shares hit a 52-week high of $26.58 and a 52-week low of $19.05.
In the last year, Catalyst Pharmaceuticals(CPRX) shares hit a 52-week high of $26.58 and a 52-week low of $19.05.
CPRX News
Catalyst Pharmaceuticals, a commercial-stage rare disease drugmaker, was recently ranked 11th on Forbes’ 2026 list of America’s Most Successful Small-Cap Compan...
